Zheqi Li

19PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCancer cell biologyGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 27, 2026
Histone H4 lysine 20 tri-methylation safeguards breast cancer lineage fidelity and unfolded protein response.

|Sep 24, 2026
Identification and validation of the ESR1 Y537S mutant-enriched enhancer and its downstream target IGFBP3.

|Aug 20, 2026
Breast cancer ovarian metastases show increased activity of GPCR pathways.

|Apr 02, 2026
HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.

Marie-Anne Goyette, Christopher Graser, Marco Seehawer

|Mar 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.

Nilgun Tasdemir, Laura Savariau, Julie Scott

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

Pageof 4

Frequent Collaborators

11 joint publications

Adrian V Lee

8 joint publications

Steffi Oesterreich

7 joint publications

Kornelia Polyak

5 joint publications

George Tseng